Skip to main content

10 Amazing Benefits of Weight Loss of 10 percent or more

Small weight loss, big gains!

Research shows that even a small amount of weight loss of only 5-10 percent of body weight may improve many of the problems associated with overweight, such as high blood pressure and diabetes. Even a smaller weight loss can make a difference. If you are trying to lose weight, do so slowly and steadily, under medical supervision. Avoid crash weight-loss diets that severely restrict calories or the variety of foods. Extreme approaches to weight loss, such as self-induced vomiting or the use of laxatives, amphetamines, or diuretics, are not appropriate and can be dangerous to your health.

Muffin Top Body or Metabolic Syndrome Body Type

Research suggests that the location of body fat also is an important factor in health risks for adults. Excess fat in the abdomen (stomach area) is a greater health risk than excess fat in the hips and thighs. Extra fat in the abdomen is linked to high blood pressure, diabetes, early heart disease, and certain types of cancer.

Smoking and too much alcohol increase abdominal fat and the risk for diseases related to obesity. Vigorous exercise helps to reduce abdominal fat and decrease the risk for these diseases. The easiest way to check your body fat distribution is to measure around your waistline with a tape measure and compare this with the measure around your hips or buttocks to see if your abdomen is larger. If you are in doubt, you may wish to seek advice from a health professional.

10 amazing benefits of weight loss of 10% or more 

1. Weight loss lowers the risks of heart disease, heart attacks, and stroke.
2. Losing weight reduces the risk of developing diabetes and helps control blood
sugar levels if you are already diabetic.
3. If you lose weight, it lowers the risk of sleep apnea, a serious breathing difficulty during sleep. Studies have shown that 10 percent weight loss reduces the risk of sleep apnea by 28 percent. So, even a small amount of weight loss goes a long way.
4. Weight loss lowers the risk of congestive heart failure. Excess weight puts stress on the heart and lungs.
5. Weight loss reduces the risks of many types of cancers including prostate cancer (Men), Breast (Women), Colon, Uterus, and many Genitourinary and Gastrointestinal Cancers.
6. Weight loss puts less stress on your bones and joints, especially the knees.
7. Losing weight reduces blood pressure. Even a small weight loss can help to lower high blood pressure.
8. Losing weight also reduces the risk of Alzheimer's dementia
9. Weight loss improves your ability to move and do activities.
10. And last, but not least, weight loss improves over 50 medication conditions and makes you feel better!


    W8MD’s NYC Weight Loss, Sleep & Medspa

    Call 718-946-5500

    Poly-Tech Sleep, W8MD’s Philadelphia Weight loss & Aesthetics NE Philadelphia

    Call 215-676-2334

    Poly-Tech Sleep, W8MD Weight Loss & MedSpa – King of Prussia, PA

    Call 215-676-2334

     Coming soon – W8MD Weight Loss, Sleep & Medical Spa Cherry Hill, NJ


    Popular posts from this blog

    What you need to know about new weight loss medication Belviq

    After a long gap of over 13 years, the FDA started approving new weight loss medications beginning with Belviq approved in June of 2012 and Qsymia approved in July 2012. After a gap of another 2 years, the FDA approved two new weight loss medications in late 2014 with Contrave approved in September and Saxenda in December. Let us review these 4 new weight loss medications and compare their relative utility in helping one lose weight!

    First new weight loss drug - Belviq 

    Of the four new weight loss drugs, Belviq is probably one of the safest albeit not the most potent! Since it is not a stimulant type medication, it can safely be used even in those that have had a prior history of certain cardiovascular problems in the remote past including coronary artery disease.

    When was Belviq approved for weight loss?

    The U.S. approved Belviq (lorcaserin hydrochloride), in June of 2012 in addition to a reduced-calorie diet and exercise, for chronic weight management.

    What are the indications for Bel…

    Prediabetes and diabetes

    The Epidemic of Prediabetes and Diabetes!
    According to a new study, investigators say diabetes and prediabetes will also account for an estimated 10 percent of total health care spending by the end of the decade at an annual cost of almost $500 billion. That's up from an estimated $194 billion in 2010.

    The report, "The United States of Diabetes: Challenges and Opportunities in the Decade Ahead," was unveiled this week, because November is National Diabetes Prevention month. The study offers solutions designed to improve health and life expectancy, while also saving up to $250 billion over the next 10 years.

    Read this report on CNN titled Diabetes or prediabetes predicted for half of Americans by 2020

    What is Prediabetes and why is it important to reverse it for weight loss, and prevention of diabetes?Prediabetes is a serious health condition that increases the risk of developing type 2 diabetes, heart disease, and stroke. Yet the vast majority of people with prediabetes do …

    Belviq weight loss doctor Philadelphia

    The new weight loss medication, Belviq, will be available for obesity treatment from 06/11/2013 and W8MD Medical Weight Loss Centers weight loss physicians in New York City, and Philadelphia help.

    More than one-third of U.S. adults are obese, and obesity contributes to a number of health conditions, including high blood pressure, type 2 diabetes, and high cholesterol.

    To help obese and overweight Americans who have been unsuccessful in getting their weight under control with diet and exercise, the Food and Drug Administration (FDA) has approved two new medications—the first drugs for long-term weight management that FDA has approved in 13 years.

    Marketed as Belviq and Qsymia, these prescription medications would be taken for the rest of a person’s life. “For many people, obesity is a lifelong condition, but we don’t always think of it—or treat it—as such,” says Amy Egan, M.D., M.P.H., deputy director for safety in FDA’s Division of Metabolism and Endocrinology Products (DMEP).